BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35603653)

  • 1. [The expression of interferon-stimulating gene (STING/TMEM173) in liver tissue and its correlation with liver inflammation in patients with chronic hepatitis B].
    Pan Y; Yang K; Wang C; Tian P; Yan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):446-451. PubMed ID: 35603653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of mRNA Levels of Stimulator of Interferon Genes (STING) in Individuals with Natural Immunity to Hepatitis B Virus (HBV), and in those with Chronic Hepatitis B Infection and without HBV].
    Kasap B; Buruk CK; Kaklıkkaya N; Özkaya E; Aydın Kasap Z; Aydın F
    Mikrobiyol Bul; 2020 Jan; 54(1):66-78. PubMed ID: 32050879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Virus Might Be Sensed by STING-Dependent DNA Sensors and Attenuates the Response of STING-Dependent DNA Sensing Pathway in Humans with Acute and Chronic Hepatitis B Virus Infection.
    Chen H; He G; Chen Y; Zhang X
    Viral Immunol; 2020 Dec; 33(10):642-651. PubMed ID: 33170089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation.
    Pang X; Li X; Mo Z; Huang J; Deng H; Lei Z; Zheng X; Feng Z; Xie D; Gao Z
    BMC Gastroenterol; 2018 May; 18(1):61. PubMed ID: 29743020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Wnt5a expression with liver injury in chronic hepatitis B virus infection.
    Ji XF; Zhou Q; Wang JW; Sun F; Gao S; Wang K
    BMC Infect Dis; 2023 Dec; 23(1):860. PubMed ID: 38062395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
    Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
    Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
    Yang Q; Zhang Q; Zhang X; You L; Wang W; Liu W; Han Y; Ma C; Xu W; Chen J; Yang H; Wan P; Zhou Y; Liu Y; Wu K; Yang Z; Wu J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expressions of STING but not IRF3 Molecules in Chronic HBV Infected Patients.
    Karimi-Googheri M; Daneshvar H; Khaleghinia M; Bidaki R; Kazemi Arababadi M
    Arch Iran Med; 2015 Jun; 18(6):351-4. PubMed ID: 26058929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the glutathione peroxidase 4 gene promoter is associated with the occurrence of immune tolerance phase in chronic hepatitis B.
    Su X; Wang Z; Li J; Gao S; Fan Y; Wang K
    Virol J; 2024 Mar; 21(1):72. PubMed ID: 38515187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy.
    Huang YW; Lin SC; Wei SC; Hu JT; Chang HY; Huang SH; Chen DS; Chen PJ; Hsu PN; Yang SS; Kao JH
    Antivir Ther; 2013; 18(7):877-84. PubMed ID: 23744559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Joshi SS; Gao S; Castillo E; Coffin CS
    Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.
    Yang K; Guan SH; Zhang H; Pan Y; Wu YY; Wang AH; Sun BB
    Int J Mol Sci; 2014 Nov; 15(11):21286-98. PubMed ID: 25407531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
    Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
    Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
    Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
    Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
    Sun Y; Chen HY; Xin SJ
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.
    Guo F; Tang L; Shu S; Sehgal M; Sheraz M; Liu B; Zhao Q; Cheng J; Zhao X; Zhou T; Chang J; Guo JT
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
    Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.